Nativity-specific odds ratios were obtained using conditional logistic regression, conditioning on five-year age groups, separately for US-born and foreign-born Hispanic women in SFBCS, with independent variables shown in Table 1. Specifically, the log-relative odds main effects model included the following risk factors as of the reference year (ie, the calendar year before diagnosis for case patients or before selection into the study for control participants age at first full-term pregnancy (0  = <20 years, 1 = 20–29 years, 2  = ≥30 years or nulliparous); age at menarche (2  = <12 years, 1 = 12–13 years, and 0  = ≥14 years); history of first-degree relatives with breast cancer (0 = no relatives, 1  = ≥1 relatives); history of biopsy with benign breast disease (0 = no biopsy, 1  = ≥1 biopsies). Age (in five-year age categories) was included to account for matching. The value of the log odds corresponding to variables in Table 1 and their estimated variance-covariance matrix are shown in Supplementary Table 1 (available online). The Supplementary Methods (available online) give additional details on coding and variable selection.

Table 1.

Multivariable relative risk estimates for US-born and foreign-born Hispanic women from the San Francisco Area Breast Cancer Study*

US-born HispanicsRR (95% CI)No. of case patients (n = 533)No. of control patients (n = 464)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)124134
 20–29 (1)1.26 (1.05 to 1.52)280242
 ≥30/nulliparous (2)1.59 (1.10 to 2.31)12988
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)431385
 Yes (1)1.10 (0.79 to 1.53)10279
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)445396
 Yes (1)1.18 (0.83 to 1.68)8868
Foreign-born HispanicsRR (95% CI)No. of case patients (n = 553)No. of control patients (n = 947)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)100267
 20–29 (1)1.60 (1.35 to 1.88)307526
 ≥30/nulliparous (2)2.54 (1.84 to 3.53)146154
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)468856
 Yes (1)1.62 (1.16 to 2.24)8549
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)486898
 Yes (1)2.48 (1.67 to 3.68)8549
Age at menarche (MEN), y
 ≥14 (0)1.0 (Referent)165370
 12–13 (1)1.30 (1.12 to 1.50)248391
 <12 (2)1.68 (1.26 to 2.25)140186
US-born HispanicsRR (95% CI)No. of case patients (n = 533)No. of control patients (n = 464)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)124134
 20–29 (1)1.26 (1.05 to 1.52)280242
 ≥30/nulliparous (2)1.59 (1.10 to 2.31)12988
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)431385
 Yes (1)1.10 (0.79 to 1.53)10279
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)445396
 Yes (1)1.18 (0.83 to 1.68)8868
Foreign-born HispanicsRR (95% CI)No. of case patients (n = 553)No. of control patients (n = 947)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)100267
 20–29 (1)1.60 (1.35 to 1.88)307526
 ≥30/nulliparous (2)2.54 (1.84 to 3.53)146154
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)468856
 Yes (1)1.62 (1.16 to 2.24)8549
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)486898
 Yes (1)2.48 (1.67 to 3.68)8549
Age at menarche (MEN), y
 ≥14 (0)1.0 (Referent)165370
 12–13 (1)1.30 (1.12 to 1.50)248391
 <12 (2)1.68 (1.26 to 2.25)140186
*

Estimates obtained from multivariable conditional logistic regression models separately for US-born and foreign-born Hispanic women, with risk factors coded as shown. The overall relative risk of developing invasive breast cancer, compared with an individual of the same nativity with all risk factors at their lowest risk level, is estimated by multiplying the relative risks across risk factors. CI = confidence interval; RR = relative risk.

Table 1.

Multivariable relative risk estimates for US-born and foreign-born Hispanic women from the San Francisco Area Breast Cancer Study*

US-born HispanicsRR (95% CI)No. of case patients (n = 533)No. of control patients (n = 464)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)124134
 20–29 (1)1.26 (1.05 to 1.52)280242
 ≥30/nulliparous (2)1.59 (1.10 to 2.31)12988
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)431385
 Yes (1)1.10 (0.79 to 1.53)10279
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)445396
 Yes (1)1.18 (0.83 to 1.68)8868
Foreign-born HispanicsRR (95% CI)No. of case patients (n = 553)No. of control patients (n = 947)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)100267
 20–29 (1)1.60 (1.35 to 1.88)307526
 ≥30/nulliparous (2)2.54 (1.84 to 3.53)146154
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)468856
 Yes (1)1.62 (1.16 to 2.24)8549
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)486898
 Yes (1)2.48 (1.67 to 3.68)8549
Age at menarche (MEN), y
 ≥14 (0)1.0 (Referent)165370
 12–13 (1)1.30 (1.12 to 1.50)248391
 <12 (2)1.68 (1.26 to 2.25)140186
US-born HispanicsRR (95% CI)No. of case patients (n = 533)No. of control patients (n = 464)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)124134
 20–29 (1)1.26 (1.05 to 1.52)280242
 ≥30/nulliparous (2)1.59 (1.10 to 2.31)12988
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)431385
 Yes (1)1.10 (0.79 to 1.53)10279
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)445396
 Yes (1)1.18 (0.83 to 1.68)8868
Foreign-born HispanicsRR (95% CI)No. of case patients (n = 553)No. of control patients (n = 947)
Risk factor (assigned code)
Age at first full-term pregnancy (AFP), y
 <20 (0)1.0 (Referent)100267
 20–29 (1)1.60 (1.35 to 1.88)307526
 ≥30/nulliparous (2)2.54 (1.84 to 3.53)146154
Biopsy for benign breast disease (BIOP)
 No (0)1.0 (Referent)468856
 Yes (1)1.62 (1.16 to 2.24)8549
Family history of breast cancer in first-degree female relatives (FH)
 No (0)1.0 (Referent)486898
 Yes (1)2.48 (1.67 to 3.68)8549
Age at menarche (MEN), y
 ≥14 (0)1.0 (Referent)165370
 12–13 (1)1.30 (1.12 to 1.50)248391
 <12 (2)1.68 (1.26 to 2.25)140186
*

Estimates obtained from multivariable conditional logistic regression models separately for US-born and foreign-born Hispanic women, with risk factors coded as shown. The overall relative risk of developing invasive breast cancer, compared with an individual of the same nativity with all risk factors at their lowest risk level, is estimated by multiplying the relative risks across risk factors. CI = confidence interval; RR = relative risk.

Table 2.

Projected absolute risk (%) of developing invasive breast cancer within 5, 10, 20, or 30 years by relative risk, initial age, and years of follow-up for Hispanic women*

Initial age, yYears of follow-upProject absolute risk, %
US-born Hispanic initial relative risk
Foreign-born Hispanic initial relative risk
1251012510
20
50.010.010.030.060.000.000.010.02
100.030.070.170.340.010.030.070.14
200.360.721.803.560.120.250.621.23
301.502.987.2714.010.531.062.625.17
30
50.100.200.511.020.030.070.170.34
100.330.661.643.250.110.220.551.10
201.472.927.1413.770.521.032.565.06
303.346.5715.6228.751.202.385.8511.35
40
50.460.912.264.460.160.330.811.62
101.152.295.6410.950.410.822.034.02
203.056.0014.3226.551.092.185.3510.41
305.1410.0023.0940.692.003.979.6218.30
50
50.891.774.378.550.320.631.573.11
101.953.869.3617.840.691.383.436.73
204.108.0218.8334.021.623.217.8315.03
306.0711.7426.6845.852.595.1112.2722.96
60
51.182.355.7711.200.460.912.264.47
102.284.5110.8820.550.961.904.699.16
204.378.5319.9035.581.963.899.4217.90
70
51.232.445.9911.610.551.102.735.39
102.364.6611.2221.101.102.195.3710.44
Initial age, yYears of follow-upProject absolute risk, %
US-born Hispanic initial relative risk
Foreign-born Hispanic initial relative risk
1251012510
20
50.010.010.030.060.000.000.010.02
100.030.070.170.340.010.030.070.14
200.360.721.803.560.120.250.621.23
301.502.987.2714.010.531.062.625.17
30
50.100.200.511.020.030.070.170.34
100.330.661.643.250.110.220.551.10
201.472.927.1413.770.521.032.565.06
303.346.5715.6228.751.202.385.8511.35
40
50.460.912.264.460.160.330.811.62
101.152.295.6410.950.410.822.034.02
203.056.0014.3226.551.092.185.3510.41
305.1410.0023.0940.692.003.979.6218.30
50
50.891.774.378.550.320.631.573.11
101.953.869.3617.840.691.383.436.73
204.108.0218.8334.021.623.217.8315.03
306.0711.7426.6845.852.595.1112.2722.96
60
51.182.355.7711.200.460.912.264.47
102.284.5110.8820.550.961.904.699.16
204.378.5319.9035.581.963.899.4217.90
70
51.232.445.9911.610.551.102.735.39
102.364.6611.2221.101.102.195.3710.44
*

Tables present absolute risk estimates for various initial ages, follow-up durations, and relative risks for US-born and foreign-born Hispanic women. For example, to project invasive breast cancer risk over 20 years for a 30-year-old foreign-born Hispanic woman who had her first full-term pregnancy at age 28 years (age at first full-term pregnancy [AFP] = 1), who never had a biopsy for benign breast disease (biopsy for benign breast disease [BIOP] = 0), whose mother had breast cancer (family history of breast cancer in first-degree female relatives [FH] = 1), and who began menstruating at age 11 years (age at menarche [MEN] = 2). From Table 1, the woman’s relative risk is 1.60 (for AFP = 1) x 1.00 (for BIOP = 0) x 2.48 (for FH = 1) x 1.68 (for MEN = 2) = 6.67. As shown in the table, the woman’s 20-year absolute risk is between 2.56% for relative risk 5 and 5.06% for relative risk 10. By linear interpolation, the approximate risk is 2.56 + (5.06–2.56)(6.67–5.00)/(10–5) = 3.40%.

Table 2.

Projected absolute risk (%) of developing invasive breast cancer within 5, 10, 20, or 30 years by relative risk, initial age, and years of follow-up for Hispanic women*

Initial age, yYears of follow-upProject absolute risk, %
US-born Hispanic initial relative risk
Foreign-born Hispanic initial relative risk
1251012510
20
50.010.010.030.060.000.000.010.02
100.030.070.170.340.010.030.070.14
200.360.721.803.560.120.250.621.23
301.502.987.2714.010.531.062.625.17
30
50.100.200.511.020.030.070.170.34
100.330.661.643.250.110.220.551.10
201.472.927.1413.770.521.032.565.06
303.346.5715.6228.751.202.385.8511.35
40
50.460.912.264.460.160.330.811.62
101.152.295.6410.950.410.822.034.02
203.056.0014.3226.551.092.185.3510.41
305.1410.0023.0940.692.003.979.6218.30
50
50.891.774.378.550.320.631.573.11
101.953.869.3617.840.691.383.436.73
204.108.0218.8334.021.623.217.8315.03
306.0711.7426.6845.852.595.1112.2722.96
60
51.182.355.7711.200.460.912.264.47
102.284.5110.8820.550.961.904.699.16
204.378.5319.9035.581.963.899.4217.90
70
51.232.445.9911.610.551.102.735.39
102.364.6611.2221.101.102.195.3710.44
Initial age, yYears of follow-upProject absolute risk, %
US-born Hispanic initial relative risk
Foreign-born Hispanic initial relative risk
1251012510
20
50.010.010.030.060.000.000.010.02
100.030.070.170.340.010.030.070.14
200.360.721.803.560.120.250.621.23
301.502.987.2714.010.531.062.625.17
30
50.100.200.511.020.030.070.170.34
100.330.661.643.250.110.220.551.10
201.472.927.1413.770.521.032.565.06
303.346.5715.6228.751.202.385.8511.35
40
50.460.912.264.460.160.330.811.62
101.152.295.6410.950.410.822.034.02
203.056.0014.3226.551.092.185.3510.41
305.1410.0023.0940.692.003.979.6218.30
50
50.891.774.378.550.320.631.573.11
101.953.869.3617.840.691.383.436.73
204.108.0218.8334.021.623.217.8315.03
306.0711.7426.6845.852.595.1112.2722.96
60
51.182.355.7711.200.460.912.264.47
102.284.5110.8820.550.961.904.699.16
204.378.5319.9035.581.963.899.4217.90
70
51.232.445.9911.610.551.102.735.39
102.364.6611.2221.101.102.195.3710.44
*

Tables present absolute risk estimates for various initial ages, follow-up durations, and relative risks for US-born and foreign-born Hispanic women. For example, to project invasive breast cancer risk over 20 years for a 30-year-old foreign-born Hispanic woman who had her first full-term pregnancy at age 28 years (age at first full-term pregnancy [AFP] = 1), who never had a biopsy for benign breast disease (biopsy for benign breast disease [BIOP] = 0), whose mother had breast cancer (family history of breast cancer in first-degree female relatives [FH] = 1), and who began menstruating at age 11 years (age at menarche [MEN] = 2). From Table 1, the woman’s relative risk is 1.60 (for AFP = 1) x 1.00 (for BIOP = 0) x 2.48 (for FH = 1) x 1.68 (for MEN = 2) = 6.67. As shown in the table, the woman’s 20-year absolute risk is between 2.56% for relative risk 5 and 5.06% for relative risk 10. By linear interpolation, the approximate risk is 2.56 + (5.06–2.56)(6.67–5.00)/(10–5) = 3.40%.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close